Ryan T Sullivan's Net Worth
$5.24 Million
Who is Ryan T Sullivan?
Ryan T Sullivan has an estimated net worth of $5.24 Million. This is based on reported shares across multiple companies, which include Anacor Pharmaceuticals, Inc., INTERCEPT PHARMACEUTICALS INC, and Warner Chilcott plc.
SEC CIK
Ryan T Sullivan's CIK is 0001578823
Past Insider Trading and Trends
2015 was Ryan T Sullivan's most active year for acquiring shares with 4 total transactions. Ryan T Sullivan's most active month to acquire stocks was the month of January. 2016 was Ryan T Sullivan's most active year for disposing of shares, totalling 10 transactions. Ryan T Sullivan's most active month to dispose stocks was the month of October. 2019 saw Ryan T Sullivan paying a total of $471,343.25 for 26,125 shares, this is the most they've acquired in one year. In 2016 Ryan T Sullivan cashed out on 132,573 shares for a total of $3,279,817.70, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Anacor Pharmaceuticals, Inc. No price found
EVP and General CounselRyan T Sullivan used to own units in Common Stock but no longer holds any shares there.acquired a total of 47,115 shares in Anacor Pharmaceuticals, Inc. at a cost of $535,500.00, Ryan also disposed a total of 47,115 shares of Anacor Pharmaceuticals, Inc. equalling to $4,551,453.92.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -30.13K |
$99.25 | -$2,990,601.00 |
0
|
Jun 24
| |||
Form 4
| -9.40% | -3.13K |
$66.33 | -$207,281.25 | 30.13K |
Scheduled
|
Apr 29
| ||
Form 4
| +23.14% | 6.25K |
—
|
—
| 33.26K |
Feb 3
| |||
Form 4
| -2.64% | -733.00 |
$111.78 | -$81,935.45 | 27.01K |
Scheduled
|
Jan 4
| ||
Form 4
|
—
|
0
|
$62.86 | -$951,104.97 | 27.74K |
Scheduled
|
Dec 10
| ||
Form 4
| -10.12% | -3.13K |
$53.61 | -$167,531.25 | 27.74K |
Scheduled
|
Apr 29
| ||
Form 4
| +23.46% | 5.87K |
—
|
—
| 30.86K |
Feb 3
| |||
Form 4
|
∞
| 25K |
$15.30 | $382,500.00 | 25K |
Apr 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INTERCEPT PHARMACEUTICALS INC (ICPT) No price found
General Counsel and SecretaryRyan T Sullivan owns 24,708 units of Common Stock. In the year 2018 Ryan T Sullivan filed a total of 14 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.96% | -493.00 |
$37.87 | -$18,669.91 | 24.71K |
Nov 13
| |||
Form 4
| -1.92% | -493.00 |
$51.86 | -$25,566.98 | 25.2K |
Aug 13
| |||
Form 4
| -1.88% | -493.00 |
$85.08 | -$41,944.44 | 25.69K |
May 13
| |||
Form 4
| -1.85% | -493.00 |
$94.69 | -$46,682.17 | 26.19K |
Feb 13
| |||
Form 4
| +26.57% | 5.6K |
—
|
—
| 26.68K |
Jan 23
| |||
Form 4
| -3.70% | -809.00 |
$123.92 | -$100,251.28 | 21.08K |
Dec 31
| |||
Form 4
| -14.89% | -3.83K |
$69.21 | -$588,451.75 | 21.89K |
Scheduled
|
Nov 19
| ||
Form 4
| -2.69% | -711.00 |
$68.89 | -$75,462.12 | 25.72K |
Scheduled
|
Nov 13
| ||
Form 4
| -2.54% | -689.00 |
$66.03 | -$45,494.67 | 26.43K |
Aug 13
| |||
Form 4
| -2.55% | -711.00 |
$83.73 | -$59,532.03 | 27.12K |
May 13
| |||
Form 4
| -6.61% | -1.97K |
$110.35 | -$217,499.85 | 27.83K |
Feb 13
| |||
Form 4
| +28.45% | 6.6K |
—
|
—
| 29.8K |
Jan 16
| |||
Form 4
|
∞
| 23.2K |
—
|
—
| 23.2K |
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Warner Chilcott plc No price found
VP, General Counsel & Secr.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||